TuHURA BIOSCIENCES, INC./NV Amortization of Other Deferred Charges
TuHURA BIOSCIENCES, INC./NV (HURA) reported Amortization of Other Deferred Charges of $94.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2022-09-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAmortizationOfDeferredCharges · last filed 2022-09-27
- TuHURA BIOSCIENCES, INC./NV amortization of other deferred charges for the quarter ending 2021-06-30 was $20.00K.
- TuHURA BIOSCIENCES, INC./NV amortization of other deferred charges for the quarter ending 2021-03-31 was $23.00K.
- TuHURA BIOSCIENCES, INC./NV amortization of other deferred charges for the quarter ending 2020-12-31 was $25.00K.
- TuHURA BIOSCIENCES, INC./NV amortization of other deferred charges for the quarter ending 2020-09-30 was $27.00K.
- TuHURA BIOSCIENCES, INC./NV amortization of other deferred charges for fiscal 2021 was $94.00K.
| Period end | Amortization of Other Deferred Charges 3 month | Amortization of Other Deferred Charges 6 month | Amortization of Other Deferred Charges 9 month | Amortization of Other Deferred Charges 12 month |
|---|---|---|---|---|
| 2021-06-30 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $43.00K derived: sum of 2 quarters · filed 2022-09-27 | $68.00K derived: sum of 3 quarters · filed 2022-09-27 | $94.00K 10-K · filed 2022-09-27 |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-13 | $48.00K derived: sum of 2 quarters · filed 2022-05-13 | $74.00K 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $25.00K 10-Q · filed 2022-02-11 | $51.00K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | $27.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |